-
-
-
-
-
-
-
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
-
-
-
-
-
-
-
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
-
-
-
-
-
-
-
Regeneron (REGN) Completes Acquisition of Decibel Therapeutics
-
-
-
-
-
-
-
Regeneron Reports Third Quarter 2022 Financial and Operating Results
-
-
-
-
-
-
-
Regeneron (REGN) to Purchase of Sanofi's (SNY) Stake in the Regeneron and Sanofi Collaboration on Libtayo
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/19: Super Micro and American Campus Higher; NETGEAR and Stellantis Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/06: (GRPN) (CSOD) (HOOD) Higher; (SPPI) (DRNA) (ZNGA) Lower (more...)
-
1,157,996 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

